ABVC BioPharma (ABVC) Stock Highlights

0.99 | -5.71%

2024-04-20 04:03:11

ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Statistics

Range Today

0.96 1.04

Volume Today 162.8K

Range 1 Year

0.53 6.87

Volume 1 Year 365.51M

Range 3 Year

0.5 11.69

Volume 3 Year 684.56M

Range 10 Year

0.0344 573.248

Volume 10 Year 685.18M

Highlights

Market Capitalization 10.46M (micro)

Floating Shares 6.8M

Current Price 0.99

Price To Earnings -0.43

Price To Revenue 86.03

Price To Book 0.93

Earnings Per Share -2.43

Payout Ratio 0%

Performance

Latest -5.71%

1 Month -13.91%

3 Months -19.51%

6 Months +6.45%

1 Year +50%

3 Years -77.5%

5 Years -95.6%

10 Years -99.65%

Benchmarks

Market Capitalization

342 / 368

Gross Profits

0 / 278

Total Revenue

243 / 300

Total Rank

94 / 368

Free Cashflow

45 / 352

Performance 5 years

334 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.